Trinity Biotech Invt Ltd.
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 23 institutions reported holding Trinity Biotech Invt Ltd. in their 13F filings, down 4 from Q4 2025. 5 opened new positions and 8 sold out. The largest holders were Hunter Associates Investment Management LLC ($292K), Yorkville Advisors Global, LP ($122K) and Williams & Novak, LLC ($64K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Trinity Biotech Invt Ltd.
- CUSIP
- 896438504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $138K |
| Exits | 8 | $43K |
All 13F filers, Q4 2025 → Q1 2026: 281,257 shares bought and 57,804 shares sold, net +223,453 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Hunter Associates Investment Management LLC | 0.04% | Add +1.8% | 536,210 | $292K |
| Yorkville Advisors Global, LP | 0.08% | New | 225,000 | $122K |
| Williams & Novak, LLC | 0.05% | Add +15.4% | 107,643 | $64K |
| Virtu Financial LLC | 0.00% | New | 26,676 | $14K |
| Moss Adams Wealth Advisors LLC | 0.00% | No change | 25,666 | $14K |
| Inspirion Wealth Advisors, LLC | 0.00% | No change | 25,000 | $14K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 22,280 | $12K |
| Raymond James Financial Inc. | 0.00% | No change | 20,319 | $11K |
| Becker Capital Management Inc. | 0.00% | No change | 18,000 | $10K |
| Renaissance Technologies | 0.00% | Reduce -12.3% | 17,762 | $10K |
| Geode Capital Management, LLC | 0.00% | No change | 16,642 | $9K |
| LPL Financial LLC | 0.00% | Add +18.5% | 15,036 | $8K |
| Rhumbline Advisers | 0.00% | Reduce -12.9% | 5,547 | $3K |
| Jones Financial Companies LLLP | 0.00% | No change | 3,804 | $2K |
| Wells Fargo & Company | 0.00% | New | 2,500 | $1K |
| Farther Finance Advisors, LLC | 0.00% | No change | 2,000 | $1K |
| UBS Group AG | 0.00% | Add +29.1% | 1,007 | $546 |
| Triumph Capital Management | 0.00% | No change | 1,000 | $542 |
| Simplex Trading, LLC | 0.00% | New | 555 | $300 |
| Morgan Stanley | 0.00% | Reduce -30.7% | 402 | $218 |
| Atwood & Palmer Inc. | 0.00% | No change | 20 | $11 |
| McIlrath & Eck, LLC | 0.00% | New | 5 | $3 |
| CoreCap Advisors, LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is TRINITY BIOTECH INVT LTD's weight in each manager's 13F, not the share of Trinity Biotech Invt Ltd. the manager owns.